Searchable abstracts of presentations at key conferences in endocrinology

ea0063p744 | Thyroid 2 | ECE2019

Levothyroxine treatment of subclinical (SH) and overt (OH) hypothyroidism in children with autoimmune hashimoto thyroiditis (AHT): defining the TSH cut-off level

Leka-Emiri Sofia , Petrou Vassilios , Evangelopoulou Caterina , Fotinou Aspasia , Vlachopapdopoulou Elpis , Michalacos Stefanos

Objectives: Assess the dose of levothyroxine in relation to TSH and FT4 at diagnosis of AHT in children with SH and OH.Methods: Two hundred one children (155 girls) with AHT were devided according to TSH and FT4 levels at diagnosis of hypothyroidism [SH-FT4 >1.0 ng/dl: Group 1: TSH: 5–7.5 mU/l, Group 2: TSH: >7.5 mU/l, OH: Group 3: TSH>7.5 mU/l and FT4 ≤1.0 ng/dl]. Mean L-T4 dose was reported in μg/Kg per day at diagnosis and ...

ea0049ep62 | Adrenal cortex (to include Cushing's) | ECE2017

Effect of GH treatment on coagulation and fibrinolysis parameters in prepubertal children with growth hormone deficiency

Karachaliou Feneli , Kafetzi Maria , Drakopoulou Maria , Vlachopapadopoulou Elpis , Leka-Emiris Sofia , Fotinou Aspasia , Michalakos Stefanos

Background: Increased fibrinogen levels have been reported in prepubertal children and adolescents with growth hormone deficiency (GHD), which were reduced after rhGH treatment. rhGH treatment has also been shown to exert a beneficial effect on the amount of aPAI-1 in children with GHD.Aim: Of the study was to evaluate whether prepubertal GH deficient (GHD) children showed any impairment in coagulation- and fibrinolysis-related parameters and the effect ...

ea0049ep885 | Growth hormone IGF axis - basic | ECE2017

Effect of GH treatment on coagulation and fibrinolysis parameters in prepubertal children with growth hormone deficiency

Karachaliou Feneli , Pergadou Helen , Dettoraki Anastasia , Boudouvi Evangelia , Kafetzi Maria , Fotinou Aspasia , Platokouki Helen , Papaevangelou Vassiliki

Background: Increased fibrinogen levels have been reported in prepubertal children and adolescents with growth hormone deficiency (GHD), which were reduced after rhGH treatment. rhGH treatment has also been shown to exert a beneficial effect on the amount of aPAI-1 in children with GHD. Aim of the study was to evaluate whether prepubertal GH deficient (GHD) children showed any impairment in coagulation- and fibrinolysis-related parameters and the effect of GH therapy on these ...

ea0041ep837 | Obesity | ECE2016

Metabolic syndrome and insulin resistance: can they be predicted by clinical indicators in obese prepubertal children?

Vlachopapadopoulou Elpis , Dikaiakou Eirini , Petrou Vasilis , Anagnostou Elli , Karachaliou Feneli , Patinioti Ioanna , Fotinou Aspasia , Michalacos Stefanos

Aim: To evaluate whether anthropometric indices and acanthosis nigricans can be useful markers for early detection of Insulin Resistance and Metabolic Syndrome (MetS) in overweight and obese children.Methods: Data from 510 prepubertal children (40% boys), 12.9% overweight and 87.1% obese with mean age 9.7±2.5 years were analyzed. Logistic regression analysis was used to investigate which factors were associated with HOMA-IR >3 and metabolic synd...

ea0016p703 | Thyroid | ECE2008

Results of thyroxine therapy on thyroid nodules size in children with Hashimoto's thyroiditis

Skarpa Vassiliki , Tertipi Athanasia , Petrou Vassilios , Kostakioti Eleni , Posaghidou Elvira , Kousta Eleni , Papachilleos Petros , Kitsopoulou Aphroditi , Vakaki Marina , Fotinou Aspasia , Ioanidis Dimitris , Papathanasiou Asteroula , Hadjiathanasiou Charalambos

Aim: To study the effect of thyroxine treatment on the size of thyroid nodules in children with Hashimoto’s thyroiditisPatients and methods: Twenty-two girls and 6 boys (78.6/21.4%) were followed for 2 years under thyroxine therapy, at mean dose 1.6±0.4 μg/kg per day. Diagnosis of Hashimoto’s thyroiditis was based on the high value of either antithyroid antibodies, ATPO or ATG. Age at presentation was 10.6±2.0 year (6.2–13.6...